{"id":1068016,"date":"2020-11-13T00:51:51","date_gmt":"2020-11-13T05:51:51","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/sun-biopharma-inc-provides-business-update-and-reports-q3-2020-financial-results\/"},"modified":"2024-08-18T11:41:57","modified_gmt":"2024-08-18T15:41:57","slug":"sun-biopharma-inc-provides-business-update-and-reports-q3-2020-financial-results","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/sun-biopharma-inc-provides-business-update-and-reports-q3-2020-financial-results.php","title":{"rendered":"Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results"},"content":{"rendered":"<p><![CDATA[MINNEAPOLIS, Nov.  12, 2020  (GLOBE NEWSWIRE) -- Sun BioPharma, Inc. (Nasdaq: SNBP), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with pancreatic cancer, today provides a business update and reports financial results for the quarter ended September 30, 2020. Management is hosting an earnings call today at 4:30 p.m. ET.]]><\/p>\n<p>Read more:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/12\/2126068\/0\/en\/Sun-BioPharma-Inc-Provides-Business-Update-and-Reports-Q3-2020-Financial-Results.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results\">Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read more: Sun BioPharma, Inc. Provides Business Update and Reports Q3 2020 Financial Results <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/sun-biopharma-inc-provides-business-update-and-reports-q3-2020-financial-results.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068016","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068016"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068016"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068016\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068016"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068016"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068016"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}